Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis
Introduction: Studies in antineutrophil cytoplasmic autoantibody (ANCA)–associated vasculitis (AAV) consistently show that the months following diagnosis have the greatest impact on the long-term renal function. Yet, it remains uncertain how much early gain should be expected with treatment. We soug...
Main Authors: | Fanny Lepeytre, Virginie Royal, Pierre-Luc Lavoie, Guillaume Bollée, François Gougeon, Stéphanie Beauchemin, Maxime Rhéaume, Soumeya Brachemi, Louis-Philippe Laurin, Stéphan Troyanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-04-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919300476 |
Similar Items
-
Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01) -
Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01) -
ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01) -
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01) -
ANCA-positive vasculitis: Clinical implications of ANCA types and titers
by: Vital Manuel Da Silva Domingues, et al.